Aniview Support Cancer Immunotherapy Research: Identification of ADAM12 as a Fibroblast Checkpoint via Single-Cell Screening

New progress has been made in identifying novel targets for cancer immunotherapy through single-cell screening.

Learn More

Aniview Support Tumor Immunotherapy Research: An Epigenetic Nano-Agonist Promotes T Cell Priming, Recruitment, and Reactivation in PD-L1–Resistant Tumors

New progress has been made in the field of immunotherapy for PD-L1–resistant tumors.

Learn More

Aniview Support Tumor Immunotherapy Research: Antibody-Mediated Chemical Engineering of γδ T Cells Targeting Cancer Cells for Enhanced Tumor Immunotherapy

This study provides new insights into antibody-mediated chemical engineering of γδ T cells for enhancing tumor-targeting capability and improving antitumor immune responses.

Learn More

Shaping the Future of Imaging: Biolight Biotechnology Shines at Analytica 2026 in Munich, Showcasing the Strength of Chinese Innovation

Through comprehensive technological innovation and intelligent solutions, Biolight Biotechnology once again demonstrated the R&D strength and innovation capacity of Chinese high-end scientific instruments, becoming one of the most prominent representatives of Chinese innovation at the exhibition.

Learn More

BLT Secures Orders from Multiple Countries, AniView Series In Vivo Imaging Systems Demonstrate International Competitiveness

Recently, Guangzhou Biolight Biotechnology Co., Ltd. (hereinafter referred to as “BLT”) announced that its core product, the AniView series of live imaging systems, has secured a series of significant orders in overseas markets.

Learn More

BLT and UCLA Crump Institute Establish First Joint In Vivo Imaging Demonstration Center in North America

On 2025 November 7, the UCLA Crump Institute for Molecular Imaging (CIMI-UCLA) and Guangzhou Biolight Technology Co., Ltd. (BLT) jointly announced the establishment of the CIMI-UCLA & BLT In Vivo Imaging Center at the University of California, Los Angeles.

Learn More

Bridging the Middle East Through Technology - BLT Presents Full-Spectrum Imaging Innovation at NYU Abu Dhabi

New York University Abu Dhabi (NYUAD) recently hosted a seminar and technical workshop featuring Guangzhou Biolight Biotechnology Co., Ltd. (hereinafter referred to as BLT) , invited to present its cutting-edge AniView Phoenix100 Full-Spectrum In Vivo Imaging System.

Learn More

BLT Shines at ARABLAB LIVE 2025, Deepening Strategic Layout in the Middle East and South Asia

Following a successful debut in 2024, the BLT team returned to ARAB LAB 2025, showcasing its technological strength through a full range of offerings—from advanced research equipment to high-quality reagents.

Learn More